145 related articles for article (PubMed ID: 17351944)
21. K-ras mutation analysis of residual liquid-based cytology specimens from endoscopic ultrasound-guided fine needle aspiration improves cell block diagnosis of pancreatic ductal adenocarcinoma.
Sekita-Hatakeyama Y; Nishikawa T; Takeuchi M; Morita K; Takeda M; Hatakeyama K; Nakai T; Uchiyama T; Itami H; Fujii T; Mitoro A; Sho M; Ohbayashi C
PLoS One; 2018; 13(3):e0193692. PubMed ID: 29494669
[TBL] [Abstract][Full Text] [Related]
22. Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes.
Immervoll H; Hoem D; Kugarajh K; Steine SJ; Molven A
Virchows Arch; 2006 Jun; 448(6):788-96. PubMed ID: 16598499
[TBL] [Abstract][Full Text] [Related]
23. DNA mutational differences in cytological specimens from pancreatic cancer and cholangiocarcinoma.
Fasanella KE; Krasinskas A; Schoedel KE; Sasatomi E; Slivka A; Whitcomb DC; Sanders M; Nodit L; Raab S; McGrath KM; Ohori NP; Khalid A
Pancreatology; 2010; 10(4):429-33. PubMed ID: 20720444
[TBL] [Abstract][Full Text] [Related]
24. Accuracy and morphologic aspects of pancreatic and biliary duct brushings.
Layfield LJ; Wax TD; Lee JG; Cotton PB
Acta Cytol; 1995; 39(1):11-8. PubMed ID: 7846997
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of MSX2 mRNA in brush cytology specimens distinguished pancreatic carcinoma from chronic pancreatitis.
Satoh K; Hamada S; Kanno A; Ishida K; Ito H; Hirota M; Masamune A; Egawa S; Unno M; Shimosegawa T
Cancer Sci; 2011 Jan; 102(1):157-61. PubMed ID: 20961362
[TBL] [Abstract][Full Text] [Related]
26. EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases.
Schmid K; Oehl N; Wrba F; Pirker R; Pirker C; Filipits M
Clin Cancer Res; 2009 Jul; 15(14):4554-60. PubMed ID: 19584155
[TBL] [Abstract][Full Text] [Related]
27. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
[TBL] [Abstract][Full Text] [Related]
28. K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas.
Schoedel KE; Finkelstein SD; Ohori NP
Diagn Cytopathol; 2006 Sep; 34(9):605-8. PubMed ID: 16900481
[TBL] [Abstract][Full Text] [Related]
29. [Detection of micrometastases after curative resection for ductal adenocarcinoma of the pancreas].
Niedergethmann M; Rexin M; Knob S; Hartel M; Sturm JW; Richter A; Post S
Zentralbl Chir; 2001 Nov; 126(11):917-21. PubMed ID: 11753804
[TBL] [Abstract][Full Text] [Related]
30. Characterization of KRAS Mutation in Acinar and Langerhans Islet Cells of Patients With Pancreatic Ductal Adenocarcinoma.
Wang Z; Zhang C; Nagee K; Mohammadi A; Monteiro C
Pancreas; 2016 Mar; 45(3):337-41. PubMed ID: 26474433
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic and bile duct brushing cytology in 1000 cases: review of findings and comparison of preparation methods.
Volmar KE; Vollmer RT; Routbort MJ; Creager AJ
Cancer; 2006 Aug; 108(4):231-8. PubMed ID: 16541448
[TBL] [Abstract][Full Text] [Related]
32. Low sensitivity of the ki-ras polymerase chain reaction for diagnosing pancreatic cancer from pancreatic juice and bile: a multicenter prospective trial.
Trümper L; Menges M; Daus H; Köhler D; Reinhard JO; Sackmann M; Moser C; Sek A; Jacobs G; Zeitz M; Pfreundschuh M
J Clin Oncol; 2002 Nov; 20(21):4331-7. PubMed ID: 12409332
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of digital droplet polymerase chain reaction and digital multiplexed detection of single-nucleotide variants in pancreatic cytology specimens collected by EUS-guided FNA.
Cazacu IM; Semaan A; Stephens B; Swartzlander DB; Guerrero PA; Singh BS; Lungulescu CV; Danciulescu MM; Cherciu Harbiyeli IF; Streata I; Popescu C; Saftoiu A; Roy-Chowdhuri S; Maitra A; Bhutani MS
Gastrointest Endosc; 2021 May; 93(5):1142-1151.e2. PubMed ID: 33058885
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the novel quantitative ARMS assay and an enriched PCR-ASO assay for K-ras mutations with conventional cytology on endobiliary brush cytology from 312 consecutive extrahepatic biliary stenoses.
van Heek NT; Clayton SJ; Sturm PD; Walker J; Gouma DJ; Noorduyn LA; Offerhaus GJ; Fox JC
J Clin Pathol; 2005 Dec; 58(12):1315-20. PubMed ID: 16311354
[TBL] [Abstract][Full Text] [Related]
35. Analysis of loss of heterozygosity in atypical and negative bile duct brushing cytology specimens with malignant outcome: are "false-negative" cytologic findings a representation of morphologically subtle molecular alterations?
Krishnamurti U; Sasatomi E; Swalsky PA; Finkelstein SD; Ohori NP
Arch Pathol Lab Med; 2007 Jan; 131(1):74-80. PubMed ID: 17227126
[TBL] [Abstract][Full Text] [Related]
36. Molecular markers for diagnostic cytology of neoplasms in the head region of the pancreas: mutation of K-ras and overexpression of the p53 protein product.
van Es JM; Polak MM; van den Berg FM; Ramsoekh TB; Craanen ME; Hruban RH; Offerhaus GJ
J Clin Pathol; 1995 Mar; 48(3):218-22. PubMed ID: 7730480
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic utility of K-ras mutational analysis on bile obtained by endoscopic retrograde cholangiopancreatography.
Lee JG; Leung JW; Cotton PB; Layfield LJ; Mannon PJ
Gastrointest Endosc; 1995 Oct; 42(4):317-20. PubMed ID: 8536899
[TBL] [Abstract][Full Text] [Related]
38. Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples.
Khalid A; Pal R; Sasatomi E; Swalsky P; Slivka A; Whitcomb D; Finkelstein S
Gut; 2004 Dec; 53(12):1860-5. PubMed ID: 15542529
[TBL] [Abstract][Full Text] [Related]
39. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy.
Jimenez RE; Warshaw AL; Z'graggen K; Hartwig W; Taylor DZ; Compton CC; Fernández-del Castillo C
Ann Surg; 1999 Oct; 230(4):501-9; discussion 509-11. PubMed ID: 10522720
[TBL] [Abstract][Full Text] [Related]
40. Next-Generation Sequencing and Fluorescence in Situ Hybridization Have Comparable Performance Characteristics in the Analysis of Pancreaticobiliary Brushings for Malignancy.
Dudley JC; Zheng Z; McDonald T; Le LP; Dias-Santagata D; Borger D; Batten J; Vernovsky K; Sweeney B; Arpin RN; Brugge WR; Forcione DG; Pitman MB; Iafrate AJ
J Mol Diagn; 2016 Jan; 18(1):124-30. PubMed ID: 26596524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
